Galmed Pharmaceuticals (GLMD) Short-term Investments (2014 - 2026)

Galmed Pharmaceuticals' Short-term Investments history runs 12 years deep, the most recent figure standing at $7.8 million for Q1 2026.

• In Q1 2026, Short-term Investments rose 4.76% year-over-year to $7.8 million; the TTM figure through Mar 2026 stood at $7.8 million (up 4.76% YoY), while the FY2025 annual figure was $7.0 million, down 2.2% from the prior year.
• Short-term Investments for Q1 2026 stood at $7.8 million, up from $7.0 million in the prior quarter.
• The five-year high for Short-term Investments was $25.0 million in Q1 2022, with the low at $1.5 million in Q4 2024.
• The 5-year median for Short-term Investments is $7.8 million (2026), against an average of $9.8 million.
• The sharpest annual moves came in 2024 and 2025: Short-term Investments tumbled 80.07% in 2024, then soared 368.33% in 2025.
• Galmed Pharmaceuticals' Short-term Investments stood at $11.8 million in 2022, then plunged by 36.04% to $7.5 million in 2023, then sank by 80.07% to $1.5 million in 2024, then soared by 368.33% to $7.0 million in 2025, then grew by 10.62% to $7.8 million in 2026.
• Business Quant data shows GLMD's Short-term Investments at $7.8 million in Q1 2026, $7.0 million in Q4 2025, and $8.2 million in Q3 2025.